PortfoliosLab logoPortfoliosLab logo
IHE vs. FXAIX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

IHE vs. FXAIX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares U.S. Pharmaceuticals ETF (IHE) and Fidelity 500 Index Fund (FXAIX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IHE achieves a 11.65% return, which is significantly higher than FXAIX's 9.79% return. Over the past 10 years, IHE has underperformed FXAIX with an annualized return of 8.99%, while FXAIX has yielded a comparatively higher 15.80% annualized return.


IHE

1D
1.60%
1M
3.16%
YTD
11.65%
6M
10.97%
1Y
46.87%
3Y*
18.43%
5Y*
10.55%
10Y*
8.99%

FXAIX

1D
-0.37%
1M
0.10%
YTD
9.79%
6M
8.79%
1Y
25.51%
3Y*
21.39%
5Y*
13.60%
10Y*
15.80%
*Multi-year figures are annualized to reflect compound growth (CAGR)

IHE vs. FXAIX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
IHE
iShares U.S. Pharmaceuticals ETF
11.65%31.69%8.13%1.06%-4.87%13.07%13.66%15.47%-7.76%10.64%
FXAIX
Fidelity 500 Index Fund
9.79%17.84%25.01%26.29%-18.14%28.71%18.42%31.48%-4.43%21.82%

Correlation

The correlation between IHE and FXAIX is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.30

Correlation (3Y)
Calculated over the trailing 3-year period

0.42

Correlation (5Y)
Calculated over the trailing 5-year period

0.51

Correlation (10Y)
Calculated over the trailing 10-year period

0.58

Correlation (All Time)
Calculated using the full available price history since May 4, 2011

0.64

Over the past year, the correlation between IHE and FXAIX has dropped to 0.30 - well below their long-term average of 0.64, suggesting their price drivers have been diverging.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IHE vs. FXAIX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IHE
IHE Risk / Return Rank: 8787
Overall Rank
IHE Sharpe Ratio Rank: 8888
Sharpe Ratio Rank
IHE Sortino Ratio Rank: 9090
Sortino Ratio Rank
IHE Omega Ratio Rank: 8282
Omega Ratio Rank
IHE Calmar Ratio Rank: 9191
Calmar Ratio Rank
IHE Martin Ratio Rank: 8585
Martin Ratio Rank

FXAIX
FXAIX Risk / Return Rank: 6565
Overall Rank
FXAIX Sharpe Ratio Rank: 6464
Sharpe Ratio Rank
FXAIX Sortino Ratio Rank: 5757
Sortino Ratio Rank
FXAIX Omega Ratio Rank: 5959
Omega Ratio Rank
FXAIX Calmar Ratio Rank: 6868
Calmar Ratio Rank
FXAIX Martin Ratio Rank: 7878
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IHE vs. FXAIX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares U.S. Pharmaceuticals ETF (IHE) and Fidelity 500 Index Fund (FXAIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


IHEFXAIXDifference
Sharpe ratioReturn per unit of total volatility

+0.58

Sortino ratioReturn per unit of downside risk

+1.04

Omega ratioGain probability vs. loss probability

1.46

1.39

+0.07

Calmar ratioReturn relative to maximum drawdown

5.56

3.02

+2.54

Martin ratioReturn relative to average drawdown

17.09

13.62

+3.47

IHE vs. FXAIX - Sharpe Ratio Comparison

The current IHE Sharpe Ratio is 2.74, which is comparable to the FXAIX Sharpe Ratio of 2.15. The chart below compares the historical Sharpe Ratios of IHE and FXAIX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

IHE vs. FXAIX - Drawdown Comparison

The maximum IHE drawdown since its inception was -38.20%, which is greater than FXAIX's maximum drawdown of -33.79%. Use the drawdown chart below to compare losses from any high point for IHE and FXAIX.


Loading charts...

Drawdown Indicators


IHEFXAIXDifference

Max Drawdown

Largest peak-to-trough decline

-38.20%

-33.79%

-4.41%

Max Drawdown (1Y)

Largest decline over 1 year

-8.47%

-8.89%

+0.42%

Max Drawdown (3Y)

Largest decline over 3 years

-15.92%

-18.76%

+2.84%

Max Drawdown (5Y)

Largest decline over 5 years

-16.03%

-24.50%

+8.47%

Max Drawdown (10Y)

Largest decline over 10 years

-29.59%

-33.79%

+4.20%

Current Drawdown

Current decline from peak

-0.70%

-1.72%

+1.02%

Average Drawdown

Average peak-to-trough decline

-7.90%

-3.79%

-4.11%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.75%

1.97%

+0.78%

Volatility

IHE vs. FXAIX - Volatility Comparison

iShares U.S. Pharmaceuticals ETF (IHE) has a higher volatility of 5.27% compared to Fidelity 500 Index Fund (FXAIX) at 4.68%. This indicates that IHE's price experiences larger fluctuations and is considered to be riskier than FXAIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IHEFXAIXDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.27%

4.68%

+0.59%

Volatility (6M)

Calculated over the trailing 6-month period

12.68%

9.84%

+2.84%

Volatility (1Y)

Calculated over the trailing 1-year period

17.22%

12.50%

+4.72%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

16.28%

17.00%

-0.72%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.05%

18.12%

-0.07%

IHE vs. FXAIX - Expense Ratio Comparison

IHE has a 0.42% expense ratio, which is higher than FXAIX's 0.02% expense ratio.


Dividends

IHE vs. FXAIX - Dividend Comparison

IHE's dividend yield for the trailing twelve months is around 1.56%, more than FXAIX's 1.04% yield.


PositionTTM20252024202320222021202020192018201720162015
FXAIX
Fidelity 500 Index Fund
1.04%1.11%1.25%1.45%1.69%1.22%1.60%2.06%2.72%1.97%2.52%2.83%
IHE
iShares U.S. Pharmaceuticals ETF
1.56%1.76%1.73%1.39%2.01%1.49%1.19%1.40%1.25%1.36%0.92%1.93%

Frequently Asked Questions


IHE and FXAIX have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IHE has higher volatility (5.27%) compared to FXAIX (4.68%). In terms of maximum drawdown, IHE dropped -38.20% vs FXAIX's -33.79%.

IHE currently has the higher Sharpe Ratio (2.74 vs 2.15), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IHE and FXAIX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer